Anti-eIF5A2 + eIF5A antibody [EPR7411-6]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal eIF5A2 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Eukaryotic translation initiation factor 5A-2, eIF-5A-2, eIF-5A2, Eukaryotic initiation factor 5A isoform 2, EIF5A2, Eukaryotic translation initiation factor 5A-1, eIF-5A-1, eIF-5A1, Eukaryotic initiation factor 5A isoform 1, Rev-binding factor, eIF-4D, eIF-5A, EIF5A
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (AB126735)
Overlay histogram showing HeLa cells stained with ab126735 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab126735, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (AB126735)
ab126735 at 1/100 dilution, labeling eIF5A2 + eIF5A in Formalin fixed Paraffin-embedded Human ovarian carcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (AB126735)
All lanes:
Western blot - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (ab126735) at 1/1000 dilution
Lane 1:
293T cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Lane 4:
CaCo-2 cell lysate at 10 µg
Lane 5:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated at 1/2000 dilution
Predicted band size: 17 kDa
true
- WB
Lab
Western blot - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (AB126735)
Blocking buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (ab126735) at 1/2000 dilution
Lane 1:
Western blot - Recombinant Human eIF5A protein (Tag Free) (<a href='/en-us/products/proteins-peptides/recombinant-human-eif5a-protein-ab87457'>ab87457</a>) at 0.01 µg
Lane 2:
Western blot - Recombinant Human eIF5A2 protein (His tag N-Terminus) (<a href='/en-us/products/proteins-peptides/recombinant-human-eif5a2-protein-ab99140'>ab99140</a>) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 17 kDa
Observed band size: 15 kDa,20 kDa
false
Exposure time: 20s
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-eIF5A2 + eIF5A antibody [EPR7411-6] (AB126735)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-eIF5A2 + eIF5A antibody [EPR7411-6] - BSA and Azide free
Reactivity data
Product details
This product was previously published with the name Anti-eIF5A2 antibody [EPR7411-6]. Following in-house testing that showed reactivity to both recombinant Human eIF5A protein (ab87457) and recombinant Human eIF5A2 protein (ab99140), the name was updated in January 2021 to Anti-eIF5A2 + eIF5A antibody [EPR7411-6].
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein eIF5A2 is involved in diverse cellular processes beyond translation. It localizes in both the cytoplasm and nucleus affecting cell proliferation differentiation and apoptosis. eIF5A2 is not traditionally considered as part of a complex but interacts with ribosomes during the translation process to exert its function. It also influences the synthesis of specific proteins that are important for maintaining cell cycle machinery and responses to stress.
Pathways
EIF5A2 integrates into the regulation of translation and apoptosis pathways. One key pathway involves its links to the mTOR signaling pathway which affects cell growth and survival. Similar proteins involved in this network include eIF5A another isoform closely related to eIF5A2 and components of the ribosomal machinery. eIF5A2 through its effects on protein synthesis influences pathways that coordinate cellular responses to nutrient availability and growth signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
International journal of oncology 57:1368-1380 PubMed33174013
2020
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 10:1151-1165 PubMed31938057
2020
Applications
Unspecified application
Species
Unspecified reactive species
Bioscience, biotechnology, and biochemistry 83:400-408 PubMed30551723
2018
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 10:e0119229 PubMed25793713
2015
Applications
Unspecified application
Species
Unspecified reactive species
American journal of reproductive immunology (New Y 71:229-40 PubMed24382123
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com